Post-infectious functional gastrointestinal disorders (FGID) are a relatively well-studied phenomenon among individuals who are resident in temperate and higher-income regions around the world. Less is known about the risk of FGID among residents in tropical and hyperendemic settings where acute gastroenteritis risk and exposure is high. This editorial summarizes the primary results from a recently published study focusing on this unique clinical scenario and considers the interpretation of the data as well as highlights additional research needs.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1038/s41395-018-0206-5 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Soluble Membrane Attack Complex (sMAC) as a Potential Diagnostic Biomarker Differentiating Acute Viral Encephalitis from Guillain-Barré Syndrome, a Post-infectious Autoimmune State.
Curr Microbiol
December 2024
Department of Virus Research, Manipal Institute of Virology, Manipal Academy of Higher Education, Manipal, 576104, Karnataka, India.
Acute encephalitis syndrome (AES) presents with the onset of fever, altered sensorium and/or seizures, known to be caused by various infectious and non-infectious aetiological agents, among which viruses are the commonest. The severity of AES prompts rapid diagnosis, which is not met by time-consuming conventional diagnostic techniques. In this study, archived cerebrospinal fluid samples of laboratory-confirmed viral AES, an acute infectious condition and Guillain-Barré Syndrome (GBS), a post-infectious, autoimmune condition was assessed for soluble membrane attack complex (sMAC) using ELISA.
View Article and Find Full Text PDFNon-Hospitalized Patients With Post-COVID Condition and Myopathic Electromyography Findings Show no Difference in Symptom Severity and Clinical Manifestations Compared to Those Without Myopathic Findings.
Muscle Nerve
December 2024
Unit of Clinical Neurophysiology, Karolinska University Hospital, Stockholm, Sweden.
Introduction: The COVID-19 pandemic has resulted in a post-infectious syndrome designated as long-COVID or post-COVID condition (PCC) that presents with numerous symptoms including fatigue and myalgias. This study evaluated myopathic electromyography (EMG) findings in non-hospitalized PCC patients in relation to symptom severity, quality of life (QoL), and physical function.
Methods: Twenty-nine PCC patients with persistent symptoms ≥ 3 months after laboratory-confirmed SARS-CoV-2 infection, without hospitalization or comorbidities, were included.
Case report: A diabetic patient with cryptococcal meningoencephalitis complicated by post-infectious inflammatory response syndrome.
Front Immunol
December 2024
Department of Neurology Medicine, The Second Hospital of Shandong University, Cheeloo College of Medicine of Shandong University, Shandong University, Jinan, China.
We report on a previously non-HIV-diagnosed, 47-year-old male diagnosed with diabetes mellitus (DM) and cryptococcal meningoencephalitis, who was referred to our institution for antifungal treatment. During the course of treatment, due to the development of refractory intracranial hypertension, Ommaya reservoirs were employed for cranial pressure reduction. The patient gradually recovered during subsequent antifungal therapy; however, symptoms worsened in the third month of treatment, leading to consideration of post-infectious inflammatory response syndrome (PIIRS) on examination.
View Article and Find Full Text PDFLate Recurrence of C3 Glomerulopathy After SARS-CoV-2 Infection in a Long-Term Kidney Transplant Recipient: A Case Report.
Am J Case Rep
December 2024
Department of Translational Medicine and Surgery, Università Cattolica del Sacro Cuore, Roma, Italy.
Article Synopsis
- Kidney transplantation is the best treatment for end-stage kidney disease, but long-term success can be affected by issues like recurrence of native kidney diseases such as C3 glomerulopathy (C3GN).
- A case study documented a female kidney transplant recipient whose kidney function declined after 28 years due to two SARS-CoV-2 infections, alongside evidence of chronic rejection and features of C3GN in her recent biopsy.
- The findings suggest that C3GN may have recurred late in this patient as a result of complement activation triggered by the SARS-CoV-2 infections, indicating a potential new risk factor for post-transplant complications.
Anti-CdtB and anti-vinculin antibodies to diagnose irritable bowel syndrome in inflammatory bowel disease patients.
BMC Gastroenterol
December 2024
Department of Gastroenterology, University of Sao Paulo School of Medicine, Av. Dr. Eneas C Aguiar 255, Sao Paulo-SP, 9117, Brazil.
Background: Despite adequate treatment, a subgroup of patients with inflammatory bowel disease (IBD), including Crohn`s disease and ulcerative colitis, have persistent gastrointestinal symptoms that are not always related to mucosal damage. Recently, two autoantibodies, anti-CdtB and anti-vinculin, were validated as post-infectious IBS (PI-IBS) markers, however there is limited evidence of its diagnostic role in IBD population.
Methods: Patients with more than 3 bowel movements/day and indication of colonoscopy were enrolled.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!